Abe, Seiichiro
Saito, Yutaka
Oono, Yasuhiro
Tanaka, Yusaku
Sakamoto, Taku
Yamada, Masayoshi
Nakajima, Takeshi
Matsuda, Takahisa
Ikematsu, Hiroaki
Yano, Tomonori
Sekine, Shigeki
Kojima, Motohiro
Yamagishi, Hidetsugu
Kato, Hiroyuki
Funding for this research was provided by:
the Japan Agency for Medical Research and Development (15ck0106028h0002)
Article History
Accepted: 13 April 2018
First Online: 26 April 2018
Compliance with ethical standards
: The study was carried on according to the ethical principles included in the Declaration of Helsinki. As intravenous fluorescein for pCLE has not been approved yet for clinical use in Japan, prior to the start of the study, we obtained the approval from the institutional review board for off-label use of intravenous fluorescein. Written informed consent was obtained from all patients.
: There was no conflict of interest to be disclosed in relation to this study.